Headquarters: Rehovot, Israel
Investor Relations: Rivka Neufeld / IR@evogene.com / +972-8-931-1900
Description
A leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform.
Industry
Life Sciences
Year Founded
Ownership
Public
Exchange / Symbol
NASDAQ: EVGN
Public Since
Chief Executive Officer
Chairman of the Board
Chief Financial Officer
Insider Ownership
Key Investors
Employee Count
Auditors
Investment Bankers
Law Firms
In the CEOs Own Words
Corporate Mission
Proudest Accomplishment
Next Milestone
Geographic Markets Served
Growth Drivers
Growth Headwinds
Indicia of Customer Satisfaction
Scalability
Workforce
Focus of Recruitment
Research and Development
Patent Count
Economic Sensitivity
Unique Metrics
Greatest Concern
Company Reports and Communications
SEC Filings
" target="_blank">